About AMEVIVE
AMEVIVE was the first biologic approved by the FDA for the treatment of moderate to severe chronic plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. AMEVIVE is a prescription medication that is injected by your doctor (15 mg IM, into the muscle) once a week for a total of 12 doses.
Looking beneath the surface
of chronic plaque psoriasis
Psoriasis starts on the inside, in your immune system, and appears on the outside as red, itchy, scaly, sometimes painful plaques. AMEVIVE is designed to act on the inside by targeting one of the causes of psoriasis, so outside, your symptoms may become more manageable.
